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Hypertensive disorders of pregnancy are a group of clinical conditions presenting in pregnant women with raised blood pressure (BP), with or without proteinuria and 
convulsions [1,2]. It affects about 5-10% of the total pregnancies 
globally, causing high maternal and neonatal morbidity and 
mortality [3]. In India, the incidence of pregnancy-induced 
hypertension (PIH) is around 15%. The incidence of pre-eclampsia 
and eclampsia is reported to be 8-10% and 0.71% of total pregnancies, 
respectively. During the past decade, the incidence of eclampsia has 
declined due to the increased awareness about antenatal checkups 
and early identification of high-risk pregnancies [4-8]. The 
hypertensive disorders of pregnancy are classified into four clinical 
categories: (1) Gestational hypertension, (2) pre-eclampsia and 
eclampsia syndrome, (3) chronic hypertension of any etiology, and 
(4) pre-eclampsia superimposed on chronic hypertension [9-11].
In normal pregnancy, there is mutual immunologic tolerance 
between the maternal tissue and the fetal (paternal) allograft. 
The endovascular trophoblasts of the placental villi destroy 
the muscular layer and autonomic innervations of the spiral 
arteries of the pregnant uterus. Meanwhile, endothelium of 
the affected arteries increases synthesis of vascular relaxing 
factors, prostacyclin, and nitric oxide. These changes result in 
uterine vasodilatation [12,13]. In pre-eclampsia, immunological 
uteroplacental maladaptation leads to disorder of trophoblastic 
invasion in the spiral arteries. The insufficient invasion and 
ingrowth of the trophoblasts inhibit vessel dilation, reducing 
maternal blood supply to the intervillous space, and thus reducing 
perfusion and causing hypoxia. The poorly perfused trophoblasts 
release some toxic substance causing vascular endothelial 
dysfunction and damage leading to pre-eclampsia. This leads to 
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uteroplacental insufficiency putting the fetus at risk of suboptimal 
intrauterine growth [4,14].
Therefore, the neonates of the mothers with PIH are at risk of 
intrauterine death, premature delivery, and small for gestational 
age, respiratory distress syndrome, transient tachypnea of new 
born, persistent pulmonary hypertension, bronchopulmonary 
dysplasia, and respiratory failure [15-17]. The derangement in the 
hematological parameters of these neonates and their association 
with clinical outcomes in newborn has shown variable results. 
Although thrombocytopenia has been a consistent finding in 
all studies, the results regarding neutropenia and red blood cell 
(RBC) indices are variable. This has left lacunae in understanding 
the burden of hematological derangement and its clinical 
implication [17-20].
Hence, the present study was planned to compare the cord 
blood hematological profile of neonates born to mothers with 
and without PIH (gestational hypertension, preeclampsia, and 
eclampsia), and to evaluate short-term clinical outcomes in the 
two groups.
METHODS
This study was a prospective case–control study, carried out at 
Neonatal division of Department of Pediatrics in collaboration 
with the Department of Obstetrics and Gynecology and 
Department of Pathology, Jawaharlal Nehru Medical College 
and Hospital, AMU, Aligarh. The study period was from January 
2015 to October 2016. Pregnant females admitted for delivery 
and their neonates were included in the study. Neonates born to 
mothers diagnosed with gestational hypertension, pre-eclampsia 
or eclampsia were included as cases and neonates born to 
normotensive mothers without any complications were included 
as controls.
Following neonates were excluded from the study: (1) 
Pregnancy complicated by risk factors associated with 
increased maternal or fetal morbidity and mortality such as 
Rh incompatibility, diabetes mellitus, and twin pregnancies; 
(2) medical illness such as renal disease, heart disease, and 
connective tissue disease; (3) those who received drugs such as 
aspirin which are likely to cause changes in hematological profile; 
(4) chronic hypertension; (5) neonates with significant congenital 
malformations; (6) severe perinatal asphyxia in the neonate; and 
(7) premature rupture of membranes (PROM).
A neonate born before 37 completed weeks of gestation 
was taken as preterm. Preterm neonates included neonates 
from 25 to 36 weeks gestation [21]. neonates with birth weight 
<10th percentile for their gestational age were taken as small 
for gestational age [21]. Mother who had more than 2 antenatal 
visits in the pregnancy was considered as a booked case. PROM 
was defined as rupture of membranes before the onset of labor. 
Membrane rupture that occurs before 37 weeks of gestation is 
referred to as preterm PROM [10]. Severe perinatal asphyxia is 
defined as no breathing efforts at birth or an Apgar score of 0-3 
at 1 min of age.
The pregnant females were diagnosed as having PIH, based 
on the working group (National High Blood Pressure Education 
Program) definition and American College of Obstetricians and 
Gynecologists criteria: [9,11]
1.	 BP	≥140/90	mmHg.
2. Proteinuria >1+ on dipstick urine protein testing.
3. +/-Edema.
4. +/-Grand mal seizures.
5. In the absence of proteinuria, thrombocytopenia (<100000 
platelets/cu mm), oliguria (<400 ml urine in 24 h) and/or 
impaired renal functions, persistent headache and visual 
symptoms, epigastria pain and/or impaired liver functions, 
respiratory distress, and cyanosis (pulmonary edema) were 
looked for, to establish the diagnosis of pre-eclampsia.
During the study period, 264 females were diagnosed as 
having PIH. Informed written consent (including consent for 
cord blood sampling) was obtained from parents/legal guardians 
of eligible participants. Out of 264 gravidas, 109 were excluded 
(reasons detailed in Fig. 1) and 155 cases were included in the 
study. For every case, a matched control was taken. Matching 
was done for age and parity of the mother, gestational age of the 
neonate, antenatal visits (booked/unbooked).
Maternal data - age, parity, antenatal visits, gestational age, 
onset of symptoms, BP recording, and presence of seizures 
and proteinuria were noted. Details of labor including mode of 
delivery, duration of labor, rupture of membranes, and presence 
of any complications during labor were also recorded. Neonatal 
data such as sex, date of birth, time of birth, Apgar scores at 1 
and 5 min were noted. Gestational age was assessed by New 
Ballard’s scoring system. Clinical examination of the neonates 
was done and findings were noted in pro forma. Anthropometric 
parameters such as length, weight, head circumference, and chest 
circumference were recorded in the standard manner.
At birth, 2 ml cord blood was collected in the 
ethylenediaminetetraacetic acid vial and was analyzed (within 
an hour) for hemoglobin (Hb), red cell indices: Packed cell 
volume (PCV), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), MCH concentration (MCHC), 
red cell distribution width (RDW), nucleated red blood cell 
(NRBC) count, reticulocyte count, total leukocyte count (TLC), 
differential leukocyte count (DLC), absolute neutrophil count 
(ANC), absolute lymphocyte count (ALC), platelet count, and 
cord blood smear examination. Hb, PCV, MCV, MCH, MCHC, 
RDW, TLC, DLC, and platelet count was estimated using Nihon 
Kohden automated cell counter method. General blood picture 
and nucleated RBCs (per 100 white blood cells) were examined 
using the smear stained with Fleishman’s stain, under Nikon E 
100 microscope. For reticulocyte count, the smear was stained 
with methylene blue (supravital stain) and examined under oil 
immersion (×100).
The cases and controls were followed up during their hospital stay 
for clinical outcome. The presence of early-onset sepsis, respiratory 
distress, and deaths were noted and were diagnosed as per the 
standard protocols. Respiratory distress was defined as the presence 
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of any two of the following features: (a) Respiratory rate >60/min; 
(b) subcostal/intercostal retractions; and (c) expiratory grunt [38]. 
Early-onset sepsis was defined as a clinical syndrome characterized 
by signs and symptoms of infection with or without accompanying 
bacteremia in the first 72 h of life [38]. Hb concentration <14 g/dL 
was taken as anemia. TLC <5000/mm3 was taken as leukopenia. 
ANC <1500/mm3 was taken as neutropenia [12]. Platelet 
<1.5 laces/mm3 was taken as thrombocytopenia. Cell morphologies 
were examined in cord blood smear for spherocytosis, anisocytosis, 
poikilocytosis, and polychromasia in erythrocytes, hypersegmented 
neutrophils, and giant thrombocytes.
Statistical analysis was done using SPSS version 20. Results 
were expressed as mean±standard deviation and percentage. 
Univariate analysis was performed using Chi-Square test 
for categorical variables and independent t-test, factorial 
ANOVA+Tukey’s post hoc tests for continuous variables. 
Bivariate correlation was tested using Pearson’s product-moment 
correlation coefficient. The p<0.05 was considered statistically 
significant, with a confidence interval (CI) of 95%. Relative risk 
(RR) of sepsis was calculated as ratio of probability of sepsis in 
case group to probability of sepsis in control group, and an RR 
of >1 means the event is more likely to occur in the experimental 
group than in the control group.
RESULTS
Out of 155 cases of PIH, 47.09% (n=73) with pre-eclampsia 
constituted the majority, 36.77% (n=57) had gestational 
hypertension and remaining 16.14% (n=25) had eclampsia. 
Besides hypertension, swelling over feet and proteinuria were 
universally present in the pre-eclampsia group. The mean 
systolic and diastolic BP in cases were 153.46±9.81 mmHg and 
117.14±8.76 mmHg, respectively, whereas in the control group, 
mean systolic and diastolic BP were 101.29±6.03 mmHg and 
79.48±3.49 mmHg, respectively. The number of lower segment 
cesarian section deliveries in cases was 53.55% (n=83) as 
compared with 30.32% (n=47) in controls (p<0.05). Baseline 
characteristics of the cases and controls are presented in Table 1.
The difference in mean values of Hb, PCV, MCV, MCH, 
and MCHC of neonates born to PIH cases and controls were not 
statistically significant as shown in Table 2. However, the difference 
in mean values of nucleated RBCs, RDW, and reticulocyte count 
between cases and controls were statistically significant. The 
difference in mean values of leukocyte indices (TLC, ANC, and 
ALC) of cases and controls was also significant. Similarly, the 
difference in incidence of leukopenia and absolute neutropenia 
between cases and controls was significant (Table 2). The platelet 
155 study 
cases
109 cases 
excluded
2ml cord blood at birth
15 – Chronic HTN, 
Renal disease
13 – PROM
15 – Twin deliveries
14 – Significant 
congenital 
malformations
10 – Severe birth 
asphyxia
12 – Rh mismatch
30 - Others
Primary Outcome:
Secondary Outcomes :
Incidence of prematurity/ growth 
retardation in neonates of PIH mothers.
Short-term clinical outcomes 
(bleeding/sepsis) during hospital stay.
155 matched 
controls
Comparison
of cord blood hematological
profile of cases and controls.
Figure 1: Study flowchart
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counts and incidence of thrombocytopenia between cases and 
controls were significant different. The difference in platelet count 
between cases with gestational hypertension, pre-eclampsia, and 
eclampsia groups was also statistically significant (Table 2).
In our study, a significant correlation was found between 
severity of maternal hypertension and neonatal platelet count in 
the cases, (Table 3).
During hospital stay, 18 neonates developed sepsis, 7 bled, 11 
had respiratory distress, and 5 expired among the cases, whereas 
11 neonates developed sepsis and 9 had respiratory distress 
among the controls (Table 4). The difference in the incidence of 
bleeding and deaths between cases and controls was statistically 
significant. Nonetheless, the RR of sepsis in cases with respect 
to controls was 1.64 and there was significant difference in the 
incidence of sepsis between neutropenia and non-neutropenic 
neonates born to PIH mothers (Tables 5 and 6).
Of 155 cases in the PIH group, 71 neonates (45.8%) were 
born preterm, whereas 40 neonates were small for gestational age 
(25.8%).
DISCUSSION
There was no significant difference between the PIH cases and 
controls in terms of mean Hb concentration and anemia (p>0.05). 
These results are in coherence with the study results of Prakash 
et al. and Sivakumar et al., who reported no significant difference 
in mean Hb concentration in their study [17,18]. Bolat et al. in 
their study on 32 PIH cases with controls, reported no significant 
Table 1: Baseline characteristics of cases and controls
Parameter Cases Controls p value
Booked status 124 (80%) 127 (82%) 0.664
Mean maternal age (years) 24.76+2.73 25.61+2.86 0.125
Primiparity 77 (49.67%) 74 (47.74%) 0.733
Mean gestational 
age (weeks)
36.18+1.62 36.21+1.81 0.869
Number of male neonates 93 (60%) 87 (56%) 0.49
Number of female neonates 62 (40%) 68 (44%) 0.49
Table 2: Comparative study of cord blood complete hemogram, cord blood smear examination, and clinical outcomes of cases and controls
Parameter Cases Controls p value
Red cell indices
Mean Hb (g/dL) 16.85±3.41 16.34±3.37 0.913
Hb <14 (g/dL) 27 (17.4%) 33 (21.3%) 0.439
Hb 14-20 (g/dL) 106 (68.38%) 102 (65.8%) 0.782
Hb >20 (g/dL) 22 (14.19%) 20 (12.9%) 0.758
PCV 46.93±12.03 45.28±6.21 0.130
MCV (fL) 102.72±13.53 101.48±4.68 0.281
MCH (pg) 36.51±4.35 36.22±7.04 0.669
MCHC (g/dl) 35.19±3.22 35.40±4.50 0.644
RDW 14.64±2.14 11.84±0.78 0.000
NRBCs (/100 WBCs) 11.18±2.33 4.32±1.32 0.000
Reticulocyte count (%) 5.18±0.49 3.83±3.59 0.000
White cell indices
Mean TLC (/µL) 11642.70±6049.96 13677.56±5711.14 0.003
Absolute TLC <5000 24 (15.48%) 05 (03.23%) 0.000
Mean ANC (µL) 5682.30±2936.56 6905.12±2932.99 0.000
ANC <1500 (/µL) 24 (15.48%) 2 (1.29%) 0.000
Mean ALC (/µL) 4955.91±2735.42 6276.89±2649.98 0.000
Mean platelet count (/µL) 164660.65±73817.05 181148.39±60921.05 0.033
Platelet count (/µL) in
Gestational hypertension 177349.12±82492.56 0.0001
Pre-eclampsia 173458.90±61947.33
Eclampsia 110040±62030.56
Platelet distribution in PIH
<1.5 lac 80 (51.61%) 49 (31.61%) 0.006
General blood picture
Erythrocyte changes 78 (50.32%) 44 (28.38%) 0.000
Neutrophil hypersegmentation 25 (16.13%) 24 (15.48%) 0.876
Giant thrombocytes 02 (1.29%) 0 0.156
Hb: Hemoglobin, PCV: Packed cell volume, MCV: Mean corpuscular volume, MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular hemoglobin concentration, 
RDW: Red cell distribution width, NRBCs: Nucleated red blood cells, TLC: Total leukocyte count, ANC: Absolute neutrophil count, ALC: Absolute lymphocyte count, 
(p<0.05)–significant
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difference in anemia, similar to our results [22]. The difference 
in mean PCV, mean MCV, mean MCH, and mean MCHC of 
PIH cases and controls were not statistically significant. Similar 
results were reported by Prakash et al. [18]; however, Sivakumar 
et al. showed a significant difference in mean MCV, which is 
contrary to our findings [17].
The difference in mean nucleated RBCs, RDW, and reticulocyte 
count of cases and controls was statistically significant (p<0.05), 
which is similar to results of the studies done by Krishna and 
Mahankali, Prakash et al., and Bolat et al. [18,20,22]. The 
increased NRBC count, RDW, and reticulocyte count in 
neonates born to PIH cases was probably due to stimulation 
of erythropoiesis in PIH, in response to tissue hypoxia, which 
leads to release of erythropoietin. Philip and Tito had postulated 
that elevated NRBCs may reflect chronic intrauterine hypoxia; 
although, the duration of hypoxemia required elevating NRBC 
count is not certain [23].
The difference in mean values of leukocyte indices (TLC, 
ANC, and ALC) of cases and controls was significant, (p<0.05). 
Similarly, the difference in incidence of leukopenia and absolute 
neutropenia between cases and controls was significant. Our 
results were similar to Bolat et al. who reported significant 
difference in TLC, ANC, and ALC [22]. Sivakumar et al. 
reported no significant difference in TLC and ANC, which was 
in conflict with our findings [17]. Nash et al. and Tsao et al. 
reported significant association of PIH with neonatal leukopenia 
and absolute neutropenia which is in coherence with our 
results [24,25].
PIH is known to be a risk factor for neutropenia, thus 
predisposing to infections. Koenig and Christensen suggested 
that neutropenia was caused by a decrease in growth factors, 
decrease in response of progenitor cells to growth factors 
and presence of inhibitor substance inhibiting neutrophil 
production [26]. Kuntz et al. reported fas–fas ligand interaction 
to be involved in leukopenia in pre-eclampsia [27]. Moallem and 
Koenid reported that in PIH, the balance of erythropoiesis and 
granulopoiesis is shifted to the direction of erythropoiesis, and 
because of hypoxia and the resulting increase in reticulopoiesis 
in normal hematopoiesis regulation, no adequate stem cells were 
left for granulopoiesis. As a result, inadequate granulopoiesis was 
observed and dysgranulopoiesis developed [28].
The platelet count and incidence of thrombocytopenia between 
cases and controls were significant different. Our results were 
similar to the results shown by Kumar and Haricharan, Prakash 
et al., Bolat et al., and Sivakumar et al. [17,18,22,29]. Kumar and 
Haricharan also reported significant difference in platelet count 
between gestational hypertension, pre-eclampsia, and eclampsia 
groups as seen in our study; however, it was contrary to results 
shown by Bolat et al., who reported no significant difference 
for the same. In our study, a significant correlation was found 
between severity of maternal hypertension and neonatal platelet 
count in the cases (p<0.05). However, Prakash et al. and Kumar 
and Haricharan could not found significant correlation for the 
same.
Although the pathophysiologic mechanism underlying 
thrombocytopenia is not clear, there are studies reporting that 
it arises from pathology at the placental level [30]. Kleckner 
et al. reported that abnormal placental endothelial surface caused 
thrombocyte destruction, and the resulting thrombocytopenia 
improved in a short time after delivery [31]. Moodley et al. reported 
that an undefined factor which leads to disseminated intravascular 
coagulation (DIC) was transported by the placenta and caused 
thrombocytopenia in the newborn [30]. Akcan et al. suggested 
the role of mediators in developing thrombocytopenia. Normally, 
vascular endothelial growth factor (VEGF) and placental growth 
factor (PlGF) are responsible for maturation of megakaryocyte 
and participate in the regulation of megakaryocyte development. 
The activity of these two factors is suppressed by sFlt 1 and 
soluble Enderlin, which are found to be raised in pre-eclampsia 
pregnancies. Low levels of PlGF and VEGF are shown in the cord 
blood of pre-eclampsia mothers’ neonates [32]. Platelet counts 
were more affected in neonates of eclamptic and pre-eclampsia 
mothers than in mothers with gestational hypertension, suggesting 
that the severity as well as the duration of hypertension is 
Table 3: Distribution of neonatal platelet count according to 
maternal blood pressure in cases. Pearson’s correlation (p<0.05 
significant, CI 95%)
Maternal 
BP (mmHg)
Neonatal platelet count (lac/µL) p value
<1 1-1.5 1.5-2 2-3 >3
Systolic BP 0.000
140-149 06 21 24 12 06
150-159 01 24 19 07 01
≥160 20 08 02 03 01
Diastolic BP <90 0 0 0 0 0 0.013
0-99 04 32 21 09 04
100-109 09 17 19 09 03
≥110 14 04 04 04 02
BP: Blood pressures, CI: Confidence interval
Table 4: Clinical outcomes during hospital stay
Parameter Cases Controls p value
Sepsis 18 (11.61%) 11 (7.09%) 0.172
Bleeding 08 (5.16%) 0 0.004
Respiratory distress 11 (7.09%) 09 (5.80%) 0.644
Deaths 05 (3.23%) 0 0.024
(Chi-Square, p<0.05 significant with CI 95%), CI: Confidence interval
Table 5: Relative risk of sepsis in cases and controls
Risk Sepsis present Sepsis absent RR
PIH 18 137 1.64
Non-PIH 11 144
PIH: Pregnancy-induced hypertension, RR: Relative risk
Table 6: Sepsis in neutropenia and non-neutropenia patients
Cases Total Sepsis p value
Neutropenia 24 08 (33.33%) 0.00
Non-neutropenia 131 10 (7.63%)
(Chi-square, p<0.05 significant, CI 95%), CI: Confidence interval
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important in influencing the platelets of neonates born to mothers 
with gestational hypertension, pre-eclampsia and eclampsia and 
eventually the final neonatal and perinatal outcome.
Erythrocyte changes were found in 78 (50.32%) cases 
and 44 (28.38%) controls, and the difference was statistically 
significant (p<0.05). Our results were in coherence with Bolat et 
al., who reported significant difference in the erythrocyte changes 
between cases and controls [22]. Because of uteroplacental 
hypoxia, there is stimulation of erythropoiesis in PIH, which 
leads to abnormal findings on peripheral smear, including 
spherocytosis, anisocytosis, and polychromasia [33-35]. No 
significant difference in giant thrombocytes on peripheral smear 
examination suggests that the present thrombocytopenia was 
caused by a moderate response of bone marrow.
In our study, the incidence of bleeding episodes and deaths 
between cases and controls was significantly different, whereas 
it was non-significant for sepsis and respiratory distress. We also 
found the increased risk of sepsis in cases and in the neonates 
with neutropenia. Our results were similar to Bhaumik et al., who 
reported an increased RR (non-significant) of sepsis in neonates 
born to PIH mothers [36]. Fuks et al. reported no significant 
difference in the incidence of respiratory distress between pre-
eclampsia cases and controls, which is in accordance with our 
findings [37]. Sivakumar et al. reported no significant difference 
in the neonatal morbidity of the cases and controls, which was in 
conflict with our findings [17]. Bleeding and death in the neonates 
of PIH cases was due to fulminant sepsis and DIC.
However, our study has few limitations as the study was done 
at tertiary center, so the results cannot be extrapolated to the 
general population. Second, neonates born to PIH mothers were 
not followed up for the course of hematological abnormalities 
with time. Furthermore, the long-term clinical outcomes were 
not studied which would have been more beneficial to assess the 
long-term impact of PIH in the neonates. Further larger studies 
are needed to find out the exact relation of clinical outcomes to 
the derangements in cord blood hematology.
CONCLUSION
Our study concludes that there are significant differences in the 
cord blood hematological profile of neonates born to mothers 
with and without PIH. Furthermore, PIH increased the RR of 
sepsis, but not significantly, with significant increase in bleeding 
and mortality in the neonate, which was reflected in their cord 
blood hematological profile in the form of leukopenia, absolute 
neutropenia, and thrombocytopenia, as well as increased NRBC 
count. Therefore, the umbilical cord blood hematological 
examination can be performed in neonates born to mothers with 
PIH, to anticipate, diagnose, and treat neonatal morbidity and 
prevent mortality.
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